Skip to main navigation
Skip to search
Skip to main content
Hamad Bin Khalifa University Home
Home
Profiles
Research units
Projects
Research output
Activities
Student theses
Search by expertise, name or affiliation
The obesity paradox in cancer, tumor immunology, and immunotherapy: Potential therapeutic implications in triple negative breast cancer
Adviti Naik
, Arta Monir Monjazeb
,
Julie Decock
*
*
Corresponding author for this work
QBRI - Translational Oncology Research Center
QBRI - Cancer Research Center
Hamad bin Khalifa University
University of California at Davis
Research output
:
Contribution to journal
›
Review article
›
peer-review
77
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The obesity paradox in cancer, tumor immunology, and immunotherapy: Potential therapeutic implications in triple negative breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Obesity Paradox
100%
Tumor Immunology
100%
Tumor Immunotherapy
100%
Immuno
25%
Lifestyle Factors
25%
Patient Cohort
25%
Immunotherapy Response
25%
Advanced or Metastatic
25%
Immune Checkpoint Therapy
25%
Tumor Survival
25%
Immune-related Adverse Events
25%
Pathological Factors
25%
Global Obesity
25%
Checkpoint Blockade
25%
Immune Contexture
25%
First Approval
25%
Immunotherapy Efficacy
25%
Clinical Cohort
25%
Immunomodulatory Effect
25%
Immunology and Microbiology
Immunotherapy
100%
Programmed Death-Ligand 1
50%
Cancer Immunotherapy
25%
Immune Response
25%
Peripheral Circulation
25%
Intravenous Immunoglobulin
25%
Atezolizumab
25%
Medicine and Dentistry
Peripheral Circulation
25%
Atezolizumab
25%
Immunoglobulin
25%
Immune-Related Adverse Events
25%
Cancer Model
25%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
20%